Concord Medical Services Holdings (CCM) EBITDA (2009 - 2025)

Concord Medical Services Holdings (CCM) has 17 years of EBITDA data on file, last reported at -$27.7 million in Q2 2025.

• For the quarter ending Q2 2025, EBITDA rose 39.91% year-over-year to -$27.7 million; the trailing twelve-month figure through Jun 2025 stood at -$150.6 million (down 1.4% YoY), and the FY2025 full-year result was -$54.0 million, down 23.12% from the prior year.
• EBITDA for Q2 2025 stood at -$27.7 million, up from -$46.1 million in the prior quarter.
• Across five years, EBITDA topped out at -$25.6 million in Q2 2021 and bottomed at -$46.1 million in Q2 2024.
• The 5-year median for EBITDA is -$31.4 million (2023), against an average of -$35.2 million.
• The widest annual swing landed in 2022, when EBITDA plunged 77.17%; it then surged 39.91% in 2025.
• A 5-year view of EBITDA shows it stood at -$25.6 million in 2021, then sank by 77.17% to -$45.4 million in 2022, then surged by 30.83% to -$31.4 million in 2023, then slumped by 46.79% to -$46.1 million in 2024, then soared by 39.91% to -$27.7 million in 2025.
• The last three EBITDA figures came in at -$27.7 million (Q2 2025), -$46.1 million (Q2 2024), and -$31.4 million (Q2 2023), per Business Quant data.

Peer Comparison